Startup secures $3m to boost healthcare access in Nigeria
MDaaS Global, healthtech company and operator of Nigeria’s healthcare network – BeaconHealth Diagnostics, has raised a $3m pre-series A round of financing.
The startup announced in a statement on Wednesday that the round was co-led by Aruwa Capital Management and follow-on investor Newtown Partners.
It also landed additional follow-on investment from Ventures Platform, one of the company’s earliest institutional investors.
It said the new round of financing brings MDaaS Global’s total investment to date to $6.8m.
According to the startup, the additional capital will be used to further develop the company’s proprietary technology platform, BeaconOS, which it launched last year, and to expand its healthcare network to all 36 states in Nigeria through a mix of company-owned and affiliate clinics.
This strategic move propels MDaaS Global closer to its mission of democratising access to high-quality diagnostics and healthcare services across the continent.
The CEO of MDaaS Global, Oluwasoga Oni shared, “Years of operating within Nigeria’s healthcare system have given us a deep understanding of its challenges and points of friction.
“At MDaaS Global, we’re leveraging this experience to develop technology uniquely tailored to the African healthcare experience. BeaconOS isn’t just about solving our own challenges; it’s empowering our patients and partners with solutions customised to their needs and revolutionising healthcare delivery across Africa.”
Further, Oni stated, “Expanding our network across Nigeria is about more than just growth; it’s about democratising access to quality healthcare. With scale comes affordability, reach, and the ability to drive systemic change. At MDaaS Global, we’re not just building clinics or software; we’re building a healthier future for all Nigerians, and hopefully, all Africans.”
The Founder and Managing Partner at Aruwa Capital Management, Adesuwa Rhodes said, “We are thrilled to partner with MDaaS Global on their mission to revolutionise healthcare delivery in Africa.
“MDaaS’ track record of consistent and impressive growth, as well as their dedication to bringing high-quality diagnostics to high-need patients, resonated deeply with us.
“As a gender-lens investor, we are especially excited to support a company that is driving change for women across Nigeria – over 60% of BeaconHealth patients are women, predominantly of reproductive age – and MDaaS shares our commitment to building gender-diverse teams.”
The Managing Partner at Newtown Partners, Llew Claasen said, “At Newtown Partners, we invest in companies with the potential to make transformative changes in their industries, and MDaaS Global exemplifies this ethos.
“Since first investing in MDaaS in 2021, we have been continually impressed by their ability to grow in a challenging market, their insightful approach to technology development, and their ambitious vision for expanding healthcare access across Africa.
“We are excited to further support MDaaS in their journey and are confident in their ability to deliver value to patients and stakeholders alike.”
